You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IIIB/IV non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

NSCLC Trial in New Haven, Farmington (KD019, Erlotinib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • New Haven, Connecticut
  • +1 more
May 9, 2022

Metastatic Malignant Tumor in the Lung, Stage IIIB NSCLC, Stage IV Adult Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Completed
  • Metastatic Malignant Neoplasm in the Lung
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Jun 26, 2023

    Blood Samples in Patients With Non-small Cell Lung Cancer

    Recruiting
    • Stage III Non-Small Cell Lung Cancer AJCC v7
    • +3 more
    • Biospecimen Collection
    • Laboratory Biomarker Analysis
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 18, 2022

    Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • +3 more
    • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
    • quality-of-life assessment
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Dec 7, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

    Active, not recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma Trial in

    Recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +9 more
    • Best Practice
    • +5 more
    • Columbus, Ohio
      Carolyn Presley
    Aug 30, 2022

    Nivolumab in Locally Advanced or Metastatic Non-Small Cell Lung

    Recruiting
    • Non-Small Cell Lung Cancer
      • Athens, Greece
        Local Institution
      Aug 31, 2021

      Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Trial in United States

      Recruiting
      • Lung Non-Small Cell Carcinoma
      • +5 more
      • San Francisco, California
      • +3 more
      Aug 17, 2022

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

      Active, not recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +3 more
      • New Haven, Connecticut
      • +4 more
      Jan 27, 2023

      Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,

      Active, not recruiting
      • Anorexia
      • +8 more
      • Anamorelin Hydrochloride
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

      Active, not recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +24 more
      • 18F-Fluoromisonidazole
      • +4 more
      • La Jolla, California
      • +15 more
      Jan 3, 2023

      Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

      Recruiting
      • Locally Advanced Lung Non-Small Cell Carcinoma
      • +12 more
      • Computed Tomography
      • Contrast Agent
      • New Brunswick, New Jersey
      • +1 more
      Nov 2, 2022

      Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

      Terminated
      Has Results
      • Mesothelin Positive
      • +4 more
      • Anetumab Ravtansine
      • +2 more
      • Phoenix, Arizona
      • +2 more
      Jan 5, 2023

      Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

      Active, not recruiting
      • Advanced Colorectal Carcinoma
      • +24 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 20, 2022

      NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

      Terminated
      • NSCLC
      • Rozzano, Milan, Italy
        Istituto Clinco Humanitas
      Sep 8, 2022

      Non-small-cell Lung Cancer Trial (QL1706)

      Not yet recruiting
      • Non-small-cell Lung Cancer
      • (no location specified)
      Apr 7, 2022

      NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

      Recruiting
      • NSCLC Stage IV
      • +2 more
      • Hefei, Anhui, China
      • +4 more
      Apr 15, 2023

      Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

      Not yet recruiting
      • Advanced Lung Non-Small Cell Carcinoma
      • +3 more
      • (no location specified)
      Oct 21, 2023

      Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

      Recruiting
      • Esophageal Carcinoma
      • +16 more
      • Educational Intervention
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 11, 2022